Handbook home
Quality Use of Medicines (NURS90071)
Graduate courseworkPoints: 12.5On Campus (Parkville)
About this subject
- Overview
- Eligibility and requirements
- Assessment
- Dates and times
- Further information
- Timetable (login required)(opens in new window)
Contact information
Semester 2
Overview
Availability | Semester 2 |
---|---|
Fees | Look up fees |
This subject addresses the application of pharmacokinetics and dynamics to clinical practice and introduces students to regulation and governance of prescribing, therapeutic planning across the life span, medication safety and risk and error management. This subject includes practical application of this knowledge in class and clinical practice and includes Integrated Professional Practice (IPP) hours.
Intended learning outcomes
On completion of the subject, students should be able to:
- Analyse the impact of medication use on population health outcomes with particular regard to the national health priorities, cost benefit ratio, ethics and the principles of quality use of medicines.
- Apply knowledge of basic science, pharmacokinetics and pharmacotherapeutics, best available evidence, and the principles of quality use of medicines to develop safe and effective therapeutic plans that address the consumer/patient's healthcare needs and agreed therapeutic goals.
- Partner with the consumer/patient and their family and collaborate with other healthcare professionals to identify therapeutic goals and a therapeutic plan that integrates best evidence, cost, access and respect for the consumer/patient's values and outcome goals.
- Communicate the therapeutic plan and educate the consumer/patient and, where appropriate their family, and other healthcare professionals regarding safe and effective use of medications.
- Monitor the impact of therapeutic plans on the agreed health outcomes of the individual and adjust plans accordingly and their impact on population outcomes.
- Identify measures employed to ensure safe and appropriate use of medications including drug development, drug trials and medication registration and regulation, medication reconciliation, antibiotic stewardship.
- Demonstrate ability to prescribe medications in accordance with State and Federal regulation, ethical principles, professional standards and competence.
Generic skills
- Capacity to work collaboratively with people from diverse communities to achieve goals
- Respectfully engages with Aboriginal and Torres Strait Islander Australians to understand and incorporate indigenous ways of knowing
- Communicates to effectively gather and share essential information
- Capacity to use technology and online resources to support learning and innovation
- Uses analytic and decision-making skills and system-level thinking to identify and address challenges
- Effective time management skills for planning and completing work to deadline
Last updated: 19 April 2024
Eligibility and requirements
Prerequisites
Code | Name | Teaching period | Credit Points |
---|---|---|---|
PHRM90002 | Pharmacology for Health Professionals | Semester 1 (On Campus - Parkville) |
12.5 |
Corequisites
None
Non-allowed subjects
None
Inherent requirements (core participation requirements)
The University of Melbourne is committed to providing students with reasonable adjustments to assessment and participation under the Disability Standards for Education (2005), and the Assessment and Results Policy (MPF1326). Students are expected to meet the core participation requirements for their course. These can be viewed under Entry and Participation Requirements for the course outlines in the Handbook.
Further details on how to seek academic adjustments can be found on the Student Equity and Disability Support website: http://services.unimelb.edu.au/student-equity/home
Last updated: 19 April 2024
Assessment
Description | Timing | Percentage |
---|---|---|
2 hour written examination
| Week 8 | 50% |
Completion of 20 hours of Integrated Professional Practice (IPP)
| Throughout the semester | N/A |
Four medication management plans
| Throughout the semester | 30% |
Medication prescribing competency assessment
| During the examination period | 20% |
Last updated: 19 April 2024
Dates & times
- Semester 2
Principal coordinator Snezana Kusljic Mode of delivery On Campus (Parkville) Contact hours 36 hrs contact synchronous time consisting of: 24 hours of synchronous lectures; 8 hours of online content modules; and 4 hours of online case studies. Total time commitment 170 hours Teaching period 22 July 2024 to 20 October 2024 Last self-enrol date 2 August 2024 Census date 2 September 2024 Last date to withdraw without fail 20 September 2024 Assessment period ends 15 November 2024 Semester 2 contact information
Time commitment details
75 hrs IPP (during which students will complete IPP portfolio and work-based assessment) 59 hrs to complete written assessment and review LMS content
What do these dates mean
Visit this webpage to find out about these key dates, including how they impact on:
- Your tuition fees, academic transcript and statements.
- And for Commonwealth Supported students, your:
- Student Learning Entitlement. This applies to all students enrolled in a Commonwealth Supported Place (CSP).
Subjects withdrawn after the census date (including up to the ‘last day to withdraw without fail’) count toward the Student Learning Entitlement.
Last updated: 19 April 2024
Further information
- Texts
Prescribed texts
There are no prescribed texts for this subject.
Recommended texts and other resources
A list of recommended readings will be provided upon commencement.
- Related Handbook entries
This subject contributes to the following:
Type Name Course Master of Advanced Nursing Practice (Nurse Practitioner) - Links to additional information
- Available to Study Abroad and/or Study Exchange Students
This subject is available to students studying at the University from eligible overseas institutions on exchange and study abroad. Students are required to satisfy any listed requirements, such as pre- and co-requisites, for enrolment in the subject.
Last updated: 19 April 2024